EGFR and non-small cell lung carcinoma: Similar results have been verified in F Passiglia’s study [30], which emphasized that EGFR mutation analyses in ctDNA was reliable for NSCLC, with a highly specificity (0.80) but a moderate sensitivity (0.67).